HYAL1LUCA-1, a candidate tumor suppressor gene on chromosome 3p21.3, is inactivated in head and neck squamous cell carcinomas by aberrant splicing of pre-mRNA

被引:66
作者
Frost, GI
Mohapatra, G
Wong, TM
Csóka, AB
Gray, JW
Stern, R [1 ]
机构
[1] Univ Calif San Francisco, Sch Med, Dept Pathol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Ctr Canc, San Francisco, CA 94115 USA
关键词
hyaluronidase; 3p21.3; tumor suppressor gene; aberrant splicing; squamous cell carcinoma; head and neck tumors;
D O I
10.1038/sj.onc.1203317
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The hyaluronidase first isolated from human plasma, Hyal-1, is expressed in many somatic tissues. The Hyal-1 gene, HYAL1, also known as LUCA-1, maps to chromosome 3p21.3 within a candidate tumor suppressor gene locus defined by homozygous deletions and by functional tumor suppressor activity. Hemizygosity in this region occurs in many malignancies, including squamous cell carcinomas of the head and neck, We have investigated whether cell lines derived from such malignancies expressed Hyal-1 activity, using normal human keratinocytes as controls. Hyal-1 enzyme activity and protein were absent or markedly reduced in six of seven carcinoma cell lines examined. Comparative genomic and fluorescence ill situ hybridization identified chromosomal deletions of one allele of HYAL1 in six of se, en cell lines. Initial RT-PCR analyses demonstrated marked discrepancies between levels of HYAL1 mRNA and protein. Despite repeated sequence analyses, no mutations were found, However, two species of transcripts were identified when primers were used that included the 5' untranslated region. The predominant mRNA species did not correlate with protein translation and contained a retained intron, A second spliced form lacking this intron was found only in cell lines that produced Hyal-1 protein. Inactivation of HYAL1 in these tumor lines is a result of incomplete splicing of its pre-mRNA that appears to be epigenetic in nature.
引用
收藏
页码:870 / 877
页数:8
相关论文
共 33 条
[1]  
Baylin SB, 1998, ADV CANCER RES, V72, P141
[2]  
Buchhagen DL, 1996, HEAD NECK-J SCI SPEC, V18, P529
[3]   Functional evidence for a nasopharyngeal carcinoma tumor suppressor gene that maps at chromosome 3p21.3 [J].
Cheng, Y ;
Poulos, NE ;
Lung, ML ;
Hampton, G ;
Ou, BX ;
Lerman, MI ;
Stanbridge, EJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (06) :3042-3047
[4]   Expression analysis of six paralogous human hyaluronidase genes clustered on chromosomes 3p21 and 7q31 [J].
Csoka, AB ;
Scherer, SW ;
Stern, R .
GENOMICS, 1999, 60 (03) :356-361
[5]   Purification and microsequencing of hyaluronidase isozymes from human urine [J].
Csoka, TB ;
Frost, GI ;
Wong, T ;
Stern, R .
FEBS LETTERS, 1997, 417 (03) :307-310
[6]   The hyaluronidase gene HYAL1 maps to chromosome 3p21.2-p21.3 in human and 9F1-F2 in mouse, a conserved candidate tumor suppressor locus [J].
Csóka, TB ;
Frost, GI ;
Heng, HHQ ;
Scherer, SW ;
Mohapatra, G ;
Stern, R .
GENOMICS, 1998, 48 (01) :63-70
[7]  
Druck T, 1998, ONCOL RES, V10, P341
[8]   Purification, cloning, and expression of human plasma hyaluronidase [J].
Frost, GI ;
Csoka, TB ;
Wong, T ;
Stern, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 236 (01) :10-15
[9]   A microtiter-based assay for hyaluronidase activity not requiring specialized reagents [J].
Frost, GI ;
Stern, R .
ANALYTICAL BIOCHEMISTRY, 1997, 251 (02) :263-269
[10]   The hyaluronidases: A chemical, biological and clinical overview [J].
Frost, GL ;
Csoka, T ;
Stern, R .
TRENDS IN GLYCOSCIENCE AND GLYCOTECHNOLOGY, 1996, 8 (44) :419-434